Outcomes in CKD: What we know and what we need to know

Nephron - Clinical Practice

Volumn 114, Issue 2, 2010, Pages

  Clark, Laura E ^a   Khan, Izhar ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Age related risk factors; Cardiovascular disease; Chronic kidney disease; Classification guidelines; Medicalisation of disease

Indexed keywords

ALBUMIN; CREATININE; CYSTATIN C; ESTROGEN; TESTOSTERONE;

AGED; ANEMIA; ARTERIOSCLEROSIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GROUPS BY AGE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; METABOLIC BONE DISEASE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEINURIA; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SHORT SURVEY; STROKE;

CARDIOVASCULAR DISEASES; CAUSALITY; COMORBIDITY; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 70350552145     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000254381     Document Type: Short Survey

References (47)

1. Centers for Disease Control and Prevention (CDC): Prevalence of chronic kidney disease and associated risk factors - United States, 1999-2004. MMWR Morb Mortal Wkly Rep 2007;56:161-165.
2. Stevens PE, O'Donoghue DJ, de Lusignan S, Van Vlymen J, Klebe B, Middleton R, et al: Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007;72:92-99.
3. Chronic kidney disease (stages 3-5) prevalence estimates using data from the NEOERICA study [homepage on the Internet]. www.apho.org.uk/resource/item. aspx?RID =63798 (accessed April 20, 2009).
4. Foley RN, Wang C, Snyder JJ, Collins AJ: Cystatin C levels in US adults, 1988-1994 versus 1999-2002: NHANES. Clin J Am Soc Nephrol 2009;4:965-972.
5. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, et al: Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002;39:920-929.
6. Botev R, Mallie J, Couchoud C, Schuck O, Fauvel J, Wetzels JFM, et al: Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance. Clin J Am Soc Nephrol 2009;4:899-906.
7. Glassock RJ, Winearls C: An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant 2008;23:1117-1121.
8. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9:S16-S23.
9. Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ: Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J 2006;151:492-500.
10. Kshirsagar AV, Bang H, Bomback AS, Vupputuri S, Shoham DA, Kern LM, et al: A simple algorithm to predict incident kidney disease. Arch Intern Med 2008;168:2466-2473.
11. Chonchol M, Gnahn H, Sander D: Impact of subclinical carotid atherosclerosis on incident chronic kidney disease in the elderly. Nephrol Dial Transplant 2008;23:2593-2598.
12. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001;134:629-636.
13. Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Wedel H, et al: Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) study. J Am Soc Nephrol 2001;12:218-225.
14. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999;56:2214-2219.
15. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004;15:1307-1315.
16. Menon V, Shlipak MG, Wang X, Coresh J, Greene T, Stevens L, et al: Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med 2007;147:19-27.
17. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE: Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002;106:1777-1782.
18. Culleton BF, Larson MG, Parfrey PS, Kannel WB, Levy D: Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study. Am J Med 2000;109:1-8.
19. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003;42:1050-1065.
20. Ferreira-Gonzalez I, Busse JW, Heels-Ansdell D, Montori VM, Akl EA, Bryant DM, et al: Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ 2007;334:786.
21. John R, Webb M, Young A, Stevens PE: Unreferred chronic kidney disease: a longitudinal study. Am J Kidney Dis 2004;43:825-835.
22. Drey N, Roderick P, Mullee M, Rogerson M: A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis 2003;42:677-684.
23. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164:659-663.
24. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, et al: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005;16:489-495.
25. Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, et al: Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ Online 2006;333: 1047.
26. Conway B, Webster A, Ramsay G, Morgan N, Neary J, Whitworth C, et al: Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. Nephrol Dial Transplant 2009;24: 1930-1937.
27. Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA, et al: Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 2006;69:2155-2161.
28. Magnason RL, Indridason OS, Sigvaldason H, Sigfusson N, Palsson R: Prevalence and progression of CRF in Iceland: a population-based study. Am J Kidney Dis 2002;40:955-963.
29. Lindeman RD, Tobin J, Shock NW: Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985;33: 278-285.
30. Evans M, Fryzek JP, Elinder CG, Cohen SS, McLaughlin JK, Nyren O, et al: The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis 2005;46: 863-870.
31. Eriksen BO, Ingebretsen OC: The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006;69:375-382.
32. Silbiger SR, Neugarten J: The role of gender in the progression of renal disease. Adv Ren Replace Ther 2003;10:3-14.
33. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 2000;11:319-329.
34. Eriksen BO, Ingebretsen OC: In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression. Kidney Int 2007;72:1242-1248.
35. Iseki K, Kinjo K, Iseki C, Takishita S: Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis 2004;44:806-814.
36. Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, et al: Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the Multiple Risk Factor Intervention Trial. J Am Soc Nephrol 2006;17:1444-1452.
37. Halbesma N, Kuiken DS, Brantsma AH, Bakker SJ, Wetzels JF, De Zeeuw D, et al: Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol 2006;17: 2582-2590.
38. Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR: Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 2009;20: 1069-1077.
39. Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT, et al: Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant 2008;23: 3851-3858.
40. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351: 1296-1305.
41. O'Hare AM, Bertenthal D, Covinsky KE, Landefeld CS, Sen S, Mehta K, et al: Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol 2006;17:846-853.
42. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, et al: Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 2006;17:2034-2047.
43. Manjunath G, Tighiouart H, Coresh J, Macleod B, Salem DN, Griffith JL, et al: Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 2003;63:1121-1129.
44. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al: Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005; 352:2049-2060.
45. Roderick PJ, Atkins RJ, Smeeth L, Mylne A, Nitsch DD, Hubbard RB, et al: CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis 2009;53:950-960.
46. Raymond NT, Zehnder D, Smith SC, Stinson JA, Lehnert H, Higgins RM: Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age. Nephrol Dial Transplant 2007;22:3214-3220.
47. Hallan S, Astor B, Romundstad S, Aasarod K, Kvenild K, Coresh J: Association of kidney function and albuminuria with cardiovascular mortality in older versus younger individuals: the HUNT II study. Arch Intern Med 2007;167:2490-2496.